US FDA recommends new genetic treatment to fight cancer

Cambridge Thomson Reuters

"If approved, it will be the first-ever true gene therapy treatment made available to the U.S. population and will help accelerate the speed at which we will see even more gene-based therapies come to fruition".

A panel of experts which advises the Food and Drug Administration (FDA) has unanimously voted to recommend approval of a pioneering cancer therapy from Novartis, setting up a likely approval for the first-of-its-kind treatment.

The treatment will be suitable for young people who have not been able to improve on conventional treatments, or those who have suffered a relapse that has caused the recurrence of leukemia after complete recovery, according to the report.

The therapy could be the first of a wave of treatments custom-made to target a patient's cancer.

The new therapy, called chimeric antigen receptor T cell (CAR-T) therapy, provides new hope that the disease won't just be treated, but cured. The FDA doesn't have to follow the advice of the advisory committee, but it often does.

The Swiss drug company Novartis AG, which developed the treatment, is expected to receive a decision on CTL019 by October from the FDA in October, according to Bloomberg.

"When fully commercialized, this [CTL019] therapy will no doubt save the lives of many children and young adults who have had no other effective therapy for relapsed and refractory B-cell acute lymphoblastic leukemia [ALL]", said Dr. John Maris, a pediatric oncologist at The Children's Hospital of Philadelphia.

More news: Technical glitch brings NSE to a grinding halt
More news: England announce starting XI for opening Test against South Africa
More news: Damascus vehicle bomb killed 20 - Syrian Foreign Ministry

"This review by the FDA of CAR-T therapy is a major milestone in the successful treatment of cancer", noted John Walter, CEO and president of ACGT. Called CAR-T, it involves removing immune cells from a patients' blood, reprogramming them to create an army of attack cells and putting them back into the patient.

The unanimous recommendation from the Oncologic Drugs Advisory Committee means the treatment could be approved by the FDA by the end of September, forging a new path in the immunotherapy frontier. The new treatment retrains the patient's immune system to kill tumor cells.

"When other organizations, including the (National Institutes of Health), considered gene therapy too risky, ACGT believed in the science and funded us when no one else would". The company hasn't disclosed how many patients in its trials needed immunoglobulin after treatment.

Once the material of the cells changed, they are fed back to patients. Experts say the approval will pave the way for a new era of gene-based medicines, which has shown promise in treating a wide range of diseases.

Millions T-cells (a type of immune cell) are from removed the patient's blood.

David Maloney, medical director for cellular immunotherapy at Fred Hutchinson Cancer Research Center in Seattle, said he was elated that the field is moving forward. Any lifting of the reservations on the long-term side effects of such support.

Last year, when Kite hired Christine Cassiano its new SVP of corporate communications and investor relations, she said that communication around CAR-T therapies is "about making it relatable to patients". This is also why companies like GE Healthcare are jumping into cell therapy manufacturing to offer companies like Novartis, Kite, and Juno large-scale production services. Seven dropped due to an insufficient batch of CAR-T formulation, five did not reach a 3-month followup, and four were still in the process of infusion at the data cutoff time point.

Related News:



Most liked

Hyperloop One Conducts First Full-System Test
And, of course, convincing skeptical transportation planners that this is a better solution than tried-and-true high-speed rail. Hyperloop's first trial was successful in demonstrating that the same effect could be achieved using vacuum tubes.

Limited Edition Destiny 2 PS4 Pro Bundle Announced
As has been previously announced , PS4 owners will get access to Destiny 2 bonus content before any other platform. If you're interested in picking one up, it'll set you back $449.99 and you can pre-order one from today.

AFP cool on 5 years of martial law
The attack prompted Duterte to issue Proclamation 216 declaring martial law and suspending the writ of habeas corpus in Mindanao . For its part, the military reckons that its recommendation could come out as early as this week.

Best Buy Co Inc (BBY) Tumbles As Amazon Offers Geek Squad Competitor
Apparently the company thinks smart home assistance is a big enough market to break into its own service. Now, Amazon wants to add being on your doorstep and in your home to that long, and growing list.

United Kingdom official says government has no role in Charlie Gard case
The hospital said a court should assess the claims of fresh evidence and "make its judgment on the facts". The parents of Charlie Gard have said that they're "still fighting", because Charlie is still fighting.

Iraqi Prime Minister declares victory in Mosul
About 100 ISIL fighters had earlier been reported to be trapped in a sliver of the Old City along the Tigris. Hundreds of ISIS militants are estimated remaining in the Old City inside the allies and nearby buildings.

Man arrested at airport over Manchester attack
The Manchester bombing police are working with authorities in Libya to speak to Hashem, who is being held by anti-terror police. We do however suspect others were either aware of or complicit in the knowledge of this attack.

Splatoon 2 gets companion app through Nintendo Switch Online
On release day though there still will be the Splatoon 2 Pro Controller available and a Splatoon 2 Nintendo Switch case. Thanks to the Nintendo Switch Online app, players will be able to take Nintendo wherever they go.

UK's foreign secretary backs doctors in Baby Charlie case
Great Ormond Street Hospital, where Charlie is being treated, has refused to allow Charlie to be taken out of the hospital. Charlie's mother has since told the Daily Mail that the support "has given us hope".

Merkel takes aim at United States policy ahead of G20 meeting with Trump
Mounted police units, thousands of police cars, and some helicopters will be deployed to secure the two-day event. President Donald Trump will lead the USA delegation in his first visit to Germany for the meeting.

Oil Resumes Longest Rally Since 2012, But OPEC Output A Concern
Opec has exempted Nigeria and Libya from the curbs, leaving them free to ramp up output that had been sapped by local unrest. Forty-seven percent of the 15 oil market experts say there is more downside risk, but 40 percent say there should not be.

Nitish calls for "alternative narrative" for Opposition
Kumar further expressed concern over the way politics crept into presidential elections which pushed to the background the issues of the farmers.

Maryland AG issues statement on request for information on voters
To fulfill the request, Frosh said, Maryland's board of elections would have to violate state law. Officials from Kentucky, Virginia and NY , for instance, said they would not comply .

My use of social media is "Modern Day Presidential" - Donald Trump
It also says that the two "rushed into an engagement" after the Enquirer threatened to expose some of those details. Lindsey Graham saying Trump's tweet was " beneath the office and represents what is wrong with American politics ".

Hannibal Buress sent an imposter to the 'Spider-Man: Homecoming' premiere
Kevin Feige , the president of Marvel Studios, championed the cause of getting Spider-Man into the Disney-run sphere. In the meantime, Holland's return in next April's Avengers: Infinity War Part 1 can't come quick enough.